622
ERCP FOR MANAGEMENT OF POST-CHOLECYSTECTOMY BILE LEAKS IN PATIENTS WITH SUBTOTAL VERSUS TOTAL CHOLECYSTECTOMY: A COMPARATIVE ANALYSIS
Date
May 19, 2024
Tracks
Related Products
SURVIVAL BENEFIT OF NEOADJUVANT CHEMOTHERAPY IN RESECTABLE PANCREATIC CANCER – NEED BOTH ENDS OF THE SANDWICH
Pancreatic ductal adenocarcinoma (PDAC) exists in several morphological subtypes differing in prognostic significance. However, to date, a clinico-morphological correlation of these subtypes in the context of neoadjuvant therapy (NAT) has not been performed…
POST-ERCP PANCREATITIS IN PERIAMPULLARY MALIGNANCIES – A HARBINGER FOR POST-OPERATIVE COMPLICATIONS AND PANCREATIC FISTULAS
Pancreatic ductal adenocarcinoma (PDAC) exists in several morphological subtypes differing in prognostic significance. However, to date, a clinico-morphological correlation of these subtypes in the context of neoadjuvant therapy (NAT) has not been performed…
ENDOSCOPIC ULTRASOUND (EUS) BETTER PREDICTS TUMOR SIZE AND VASCULAR INVOLVEMENT COMPARED TO CROSS-SECTIONAL IMAGING IN PANCREATIC CANCER
BACKGROUND: Accurate clinical staging plays a key role in the multimodal treatment of pancreatic ductal adenocarcinoma (PDAC)…
READMISSION AFTER DISTAL PANCREATECTOMY FOR CHRONIC PANCREATITIS: COMMON AND CONSEQUENTIAL
Patients with chronic pancreatitis (CP) predominantly involving the pancreatic body/tail benefit from distal pancreatectomy (DP), with most experiencing long-term improvements in symptoms after recovery from surgery…